Skip to main content

Advertisement

Table 2 Schedule of major assessment points

From: A randomized controlled efficacy trial of behavioral activation for concurrent stimulant use and sexual risk for HIV acquisition among MSM: project IMPACT study protocol

Assessment Procedure(s)
Baseline/enrollment Eligibility screening, informed consent, interview-administered quantitative assessment, self-report battery, rapid HIV testing, toxicology screening (urine), psychiatric diagnostic assessment, blood collection for PrEP testinga
4-, 8-, 12-month follow-up visits Interview-administered quantitative assessment, self-report battery, rapid HIV testing (12-month only), toxicology screening (urine), diagnostic assessment for stimulant use disorder, blood collection for PrEP testinga
  1. aOnly participants who report being <‚ÄČ100% adherent to PrEP